Roche diabetes care, roche diabetes supplies, pimc, materials management
Ended Awarded
- Contract number
- 75H71225F28007
- Awardee
-
Roche Diabetes Care Inc. UEI F6JDDN8L9JM4
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $250,000
Award facts
- Contract value 100% obligated
- $250,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Phoenix, AZ 85016, USA
Award details come from SAM.gov/FPDS.
About this award
Roche Diabetes Care Inc. received a Firm Fixed Price Blanket Purchase Agreement (BPA) call valued at $250,000 from the Indian Health Service (IHS) on August 7, 2025, with an ultimate completion date of September 26, 2026. This non-competitive award is performed at the Phoenix Indian Medical Center in Phoenix, Arizona, and falls under the GSA's In-vitro Diagnostics, Reagents, and Test schedule (FSS-65-VII). The contract supports IHS's mission to provide comprehensive diabetes management supplies and services to American Indian and Alaska Native communities through the Phoenix facility.
This BPA call represents a child contract under Roche's existing Blanket Purchase Agreement with IHS, which was originally established on September 23, 2021, with a potential value of $2 million and specifically supports the Phoenix Indian Medical Center through September 26, 2026. Roche Diabetes Care Inc., headquartered in Indianapolis, Indiana, is an established manufacturer and federal supplier specializing in diabetes management products, including blood glucose monitors, test strips, lancets, and control solutions. The company has demonstrated consistent performance delivering critical diagnostic testing materials and medical consumables to federal healthcare organizations, with particular expertise in supporting specialized populations within the IHS and Bureau of Prisons healthcare systems.
Quick answers
Who was awarded contract 75H71225F28007?
75H71225F28007 was awarded to Roche Diabetes Care Inc. by Indian Health Service (Department of Health and Human Services) on August 7, 2025.
How much is contract 75H71225F28007 worth?
The government has obligated $250,000 on 75H71225F28007.
Is contract 75H71225F28007 an order under another contract?
Yes. 75H71225F28007 is a BPA call under V797D50597-75H71221A00014, a blanket purchase agreement, on Invitro Diagnostics, Reagents, Test (FSS-65-VII).
Was contract 75H71225F28007 competed?
The extent of competition for 75H71225F28007 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award